This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Leela Barham and Tim Wilsdon discuss the potential impact that value-based pricing (VBP) may have in the UK and the broader implications for developing international models of Health Technology Assessment (HTA). The article can be found here:
In recent years, the adoption of advanced treatments in inflammatory bowel disease has evolved. Oral products have captured a significant share in ulcerative...
The study examines the global policy landscape for invasive fungal infections, identifies key policy gaps, and underscores the need for stronger policy...
CRA is a proud sponsor of the largest annual gathering of Medical Affairs professionals, globally. Ayushman Ghosh and Brooke Bonet present the roundtable...
CRA is a proud sponsor of Paris Arbitration Week, an international and dynamic event, involving practitioners from all over the world. For more information on...
